共 50 条
- [41] Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Adenocarcinoma Following Neoadjuvant TherapyJOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (06) : 1152 - 1159Baumgartner, Joel M.Krasinskas, AlyssaDaouadi, MustaphaZureikat, AmerMarsh, WallisLee, KennethBartlett, DavidMoser, A. JamesZeh, Herbert J., III
- [42] Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Adenocarcinoma Following Neoadjuvant TherapyJournal of Gastrointestinal Surgery, 2012, 16 : 1152 - 1159Joel M. BaumgartnerAlyssa KrasinskasMustapha DaouadiAmer ZureikatWallis MarshKenneth LeeDavid BartlettA. James MoserHerbert J. Zeh
- [43] Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-AnalysisJOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 19Ratnayake, BathiyaSavastyuk, Alina Y.Nayar, ManuWilson, Colin H.Windsor, John A.Roberts, KeithFrench, Jeremy J.Pandanaboyana, Sanjay
- [44] Prognostic factors in localized pancreatic ductal adenocarcinoma after neoadjuvant therapy and resection: a systematic review and meta-analysisJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2025,Javed, Ammar A.Habib, AlyssarMahmud, OmarFatimi, Asad SaulatGrewal, MahipMughal, NabihaHe, JinWolfgang, Christopher L.Daamen, LoisBesselink, Marc G.
- [45] Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinomaScientific Reports, 9Satoshi OkuboMotohiro KojimaYoko MatsudaMasayoshi HiokiYasuhiro ShimizuHirochika ToyamaSoichiro MorinagaNaoto GotohdaKatsuhiko UesakaGenichiro IshiiMari Mino-KenudsonShinichiro Takahashi
- [46] Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinomaSCIENTIFIC REPORTS, 2019, 9 (1)Okubo, SatoshiKojima, MotohiroMatsuda, YokoHioki, MasayoshiShimizu, YasuhiroToyama, HirochikaMorinaga, SoichiroGotohda, NaotoUesaka, KatsuhikoIshii, GenichiroMino-Kenudson, MariTakahashi, Shinichiro
- [47] The Effect of Fiducials on Resection Margin and Nodal Disease in Patients Receiving Neoadjuvant Chemoradiation Therapy for Borderline Resectable Pancreatic AdenocarcinomaGASTROENTEROLOGY, 2016, 150 (04) : S322 - S322Kumar, UjjalaGarg, MrinalSharma, ManavGulati, AbhishekKulkarni, AbhijitDhawan, ManishKirichenko, AlexanderMorrissey, SuzanneMonga, DulabhAtkinson, DonaldSchiffman, SuzanneWilliams, HarryMaheshwary, RishiMitre, MarciaThakkar, Shyam
- [48] Degree of Resectability Does Not Predict Survival Among Pancreatic Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy and Surgical ResectionANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S119 - S120Kontos, F.Sekigami, Y.Michelakos, T.Fernandez del-Castillo, C.Qadan, M.Lillemoe, K. D.Ferrone, C. R.
- [49] Use of operability classifications to predict outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapyJOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)Tzeng, Ching-Wei DavidFleming, Jason B.Lee, Jeffrey EdwinXiao, LianchunPisters, Peter W. T.Vauthey, Jean-NicolasAbdalla, Eddie K.Wolff, Robert A.
- [50] Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic ductal adenocarcinomaHPB, 2022, 24 (06) : 833 - 840Schreiber, LenaZeh, RyanMonsour, ChristinaEjaz, AslamTsung, AllanPawlik, Timothy M.Miller, EricNoonan, AnneKrishna, Somashekar G.Santry, HeenaCloyd, Jordan M.